Publications

Filter
618 found

Should pharmaceuticals be allowed to transfer marketing rights for neglected diseases?

15 Feb 2005
Advocacy article

Synthetic antimalaria drug enters clinical trials

01 Oct 2004
Scientific article

Combating diseases associated with poverty

30 Sep 2004
External publication

Identification of an antimalarial synthetic trioxolane drug development candidate

19 Aug 2004
Scientific article

Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance

20 Jul 2004
External publication

Malaria’s overlooked resurgence

12 Jul 2004
Advocacy article

Antimalarial drug discovery: efficacy models for compound screening

01 Jun 2004
Scientific article

MMV Annual Report 2003

04 May 2004
MMV Annual Report

Medicines for Malaria Venture new developments in antimalarials

04 Mar 2004
Scientific article

The resurgence of Malaria and the role of the Medicines for Malaria Venture

03 Nov 2003
Advocacy article

Virtual drug discovery and development for neglected diseases through public-private partnerships

03 Nov 2003
Scientific article

Virtual drug discovery and development for neglected diseases through public–private partnerships

01 Nov 2003
Scientific article

MMV Annual Report 2002

06 May 2003
MMV Annual Report

Africa Malaria Report 2003

25 Apr 2003
External publication

MMV Annual Report 2001

07 May 2002
MMV Annual Report

Nature Insight’s supplement on Malaria

07 Feb 2002
Scientific article

Regulatory Strategies and Challenges for Neglected Infectious Diseases of High Medical Impact but Low Commercial Value: The Case of the Medicines for Malaria Venture

03 Dec 2001
Scientific article

MMV Annual Report 2000

05 Jun 2001
MMV Annual Report

Pages